EvidenceHunt

Based in Amsterdam, Netherlands, and founded by co-founders Philippe Habets and Olivier Magni, EvidenceHunt is a medical research platform that assists healthcare professionals, medical science researchers, and academic professionals in finding, analyzing, and utilizing medical evidence efficiently. In February 2025, EvidenceHunt raised EUR 1. 2 million in venture funding co-led by investors Keen Venture Partners, Dutch Founders Fund, and Slimmer AI. Individual.

EvidenceHunt's primary offering is an AI-powered research platform tailored for the medical field. The platform uses artificial intelligence to process large volumes of medical literature, allowing users to access relevant studies and scientific papers. It offers various features such as advanced search filters, AI-powered ranking intelligence, and validation tools for assessing medical research findings.  The platform's features include customizable alerts to keep users informed about the latest clinical trials and developments in specific disease areas or drugs.

Its user-friendly interface facilitates efficient navigation and retrieval of pertinent clinical evidence, supporting informed decision-making in healthcare settings. EvidenceHunt has a 25,000 active global user base. These users include professionals from healthcare, medical science, and academic fields. EvidenceHunt generates revenue through a subscription-based pricing model.

The Pro Plan cost EUR 10 per month, billed yearly. The company will use the February 2025 funding to support the enhancement of its platform capabilities.